Lazarus 3D
United States · $6.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- lazarus3d.com
- Total Funding
- $6.0M
- Last Round
- $6.0M Series AApr 2022
- Rounds
- 1
About
Lazarus 3D develops patient-specific 3D-printed surgical rehearsal tools for congenital heart disease and complex surgical planning.
Summary
Lazarus 3D is a Biotech company based in United States. It has raised $6.0M in total across 1 round, most recently a $6.0M Series A round in Apr 2022. Investors include Silverton Partners.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...